AstraZeneca PLC announced that Leif Johansson, Non-Executive Chair of the Board, intends to retire from the Board at the conclusion of the Company's Annual General Meeting (AGM) in 2023. Mr. Johansson was first elected to the Board in April 2012 and reached nine years' tenure as a Director in April 2021. Last year, the Board asked him to seek re-election at the 2021 AGM to lead the Board's oversight of completion of the acquisition of Alexion.

Again this year, the Board believes it would be in the best interests of shareholders for Mr. Johansson to seek re-election at the AGM in April 2022 and continue to serve as Chair for one further year, to facilitate succession planning and the transition to a new Chair.